Breast Cancer: Medication Use to Reduce Risk in Women Not at Increased Risk
Description of Resource:
The U.S. Preventive Services Task Force (USPSTF) recommends against the routine use of risk-reducing medications, such as tamoxifen, raloxifene, or aromatase inhibitors, in women who are not at increased risk for breast cancer. This is a D recommendation, which means the USPSTF recommends against the service. There is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits.